![]() CanSino Biologics CanSino Biologics (康希诺生物股份公司) is a biopharmaceutical company that provides solutions for the prevention and treatment of infectious diseases. | ||
Founding Date | Founding Date 1999 | Founding Date 2009 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Mechelen, BE HQ Romainville, FR Leiden, NL Basel, CH Waltham, US | Locations Tianjin, CN HQ |
Employees | Employees 70437% decrease | Employees 1,10526% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) €1.1b (FY, 2025) | Revenue (est.) ¥1.1b (FY, 2025) |
Cost of goods | Cost of goods €25.7m (FY, 2025) | Cost of goods ¥81.4m (FY, 2025) |
Gross profit | Gross profit €1.2b (FY, 2025) | Gross profit ¥1.1b (FY, 2025) |
Net income | Net income €320.9m (FY, 2025) | Net income ¥27.9m (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 3.7m | Total funding raised $ 76m |

CanSino Biologics (康希诺生物股份公司) is a biopharmaceutical company that provides solutions for the prevention and treatment of infectious diseases.
View company